Denosumab therapies are used to increase bone mass and treat osteoporosis, as well as address bone complications in cancer.

Leadiant Biosciences, Inc. announced that Health Canada has approved Cysklar® (cysteamine ophthalmic solution) 0.44%, a ...

Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called ...

“Diseases such as CIU have substantial detrimental effects on the quality of life for patients, often impacting both their physical and emotional well-being. Over the last two decades, omalizumab has ...

When Health Canada warned people last Thursday not to buy or use unauthorized injectable peptide drugs, CBC News purchased ...

Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day consultation period on using the decisions of foreign drug regulators such as ...

Ongoing price erosion in key products remains a lingering concern for Dr. Reddy's and therefore, Goldman Sachs has cut its ...